title: Optimal liver allocation for hepatocellular carcinoma: hurry up AND wait, but which one when?
authors.affiliation: Icahn School of Medicine at Mount Sinai, Recanati/Miller Transplantation Institute, New York, NY.
authors.forename: M
authors.initials: M
authors.lastname: Schwartz
authors.forename: S
authors.initials: S
authors.lastname: Florman
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D018579:Patient Selection; D066027:Transplant Recipients; D014850:Waiting Lists